MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1

Constitutive breast cancer type 1 gene (BRCA1) promoter methylation is associated with increased cancer risk, but its role in cancer-free (CF) female carriers is incompletely understood. MicroRNA (miR) is modulated during early tumorigenesis. The present study assessed the modulation of miR-126 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Showimi, Maram, Al-Yousef, Nujoud, Alharbi, Wejdan, Alkhezayem, Sara, Almalik, Osama, Alhusaini, Hamed, Alghamdi, Amani, Al-Moghrabi, Nisreen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247668/
https://www.ncbi.nlm.nih.gov/pubmed/35782895
http://dx.doi.org/10.3892/ol.2022.13396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247668/
https://www.ncbi.nlm.nih.gov/pubmed/35782895
http://dx.doi.org/10.3892/ol.2022.13396

Ejemplares similares